Impact of Etomidate vs. Propofol on Infectious Complications Post Cardiac Surgery

CompletedOBSERVATIONAL
Enrollment

1,495

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Postoperative Complications
Interventions
DRUG

Etomidate vs Propofol as induction agent

Patients undergoing cardiac surgery were induced with Etomidate according to the standard operating procedure for induction until October 1st, 2013, afterwards a new SOP with Propofol as primary induction agent was introduced. After a washout period of 3 months, Propofol was used as sole induction agent. The rest of the standard operating procedure remained the same.

Trial Locations (1)

13353

Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Augustenburger Platz 1, 13353, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT04281706 - Impact of Etomidate vs. Propofol on Infectious Complications Post Cardiac Surgery | Biotech Hunter | Biotech Hunter